What a Titer Can Prove, and What the Law Still Requires

A canine vaccine titer is a specialized blood test measuring circulating serum antibodies directed against a specific infectious virus or bacterium. For core viral pathogens—canine distemper virus (CDV), canine adenovirus type 1 and type 2 (CAV-1, CAV-2), and canine parvovirus (CPV-2)—a titer answers a medical question: has this dog mounted a measurable antibody response? It does not replace the core vaccine schedule your veterinarian recommends, and it is a different issue from rabies vaccination law. Under the 2022 AAHA Canine Vaccination Guidelines and the 2024 WSAVA Vaccination Guidelines, titers serve as an evidence-based clinical tool primarily for four distinct situations: verifying puppy seroconversion past maternal antibody interference, evaluating patients with documented histories of adverse vaccine reactions, managing dogs with suspected vaccine-associated autoimmune conditions, and advising clients with vaccine hesitancy.

A vaccine titer is a clinical laboratory measurement—it is never a legal document. In the United States, rabies control is governed by public health statutes, municipal ordinances, and state agricultural codes, not clinical discretion. The 2016 NASPHV Compendium of Animal Rabies Prevention and Control is national public-health guidance, not a federal statute. It states that rabies antibody titers do not directly correlate with protection and that circulating antibody should not be used as a substitute for current vaccination when managing exposures or deciding on boosters. A titer report does not replace the vaccination certificate a licensing office, boarding facility, or public-health investigator will ask to see. Some states put that boundary into statute: Florida Statute s. 828.30(1)(c) bars neutralizing antibody evidence as a replacement for current vaccination, while Indiana's pet-vaccination-laws page states that a rabies titer cannot be used in lieu of vaccination and that exemptions are not allowed. The vaccination mandate itself is 345 IAC 1-5-2.

Where medical exemptions exist, they require formal veterinary certification of clinical health endangerment, not a lab titer report. The sole legal environment where statutes demand a rabies titer is international movement: the CDC Dog Importation Regulations require a passing titer (at least 0.5 IU/mL) from a CDC-approved laboratory for foreign-vaccinated dogs from rabies high-risk countries if the importer wants to avoid a 28-day arrival quarantine, and destination nations such as Japan enforce approved-laboratory testing and multi-month waiting periods via USDA APHIS export protocols. Understanding what each document proves allows veterinary teams and pet owners to make informed medical decisions without running afoul of public health laws.

flowchart TD
  Start["Why is a titer being considered?"] --> Q1{"Which antigen?"}

  Q1 -->|Core viruses: CDV, CPV, CAV| CoreFlow["Core viral antibody test"]
  Q1 -->|Rabies| RabiesFlow["Rabies: law versus travel"]
  Q1 -->|Non-core: Lepto, Lyme, Bordetella| NonCoreFlow["Not a protection check"]

  NonCoreFlow --> NonCoreRes["No established protective threshold<br/>Diagnostic MAT-style results are a different question<br/>They do not set booster intervals"]

  CoreFlow --> CoreContext{"Clinical scenario"}
  CoreContext -->|Puppy end of series| PupCheck["Confirm seroconversion past MDA<br/>WSAVA: sample at or after 20 weeks<br/>and at least 4 weeks after last dose"]
  CoreContext -->|Adverse reaction or autoimmune concern| ReactCheck["AAHA exceptions to routine titering"]
  CoreContext -->|Vaccine-hesitant household| HesCheck["AAHA: owners who resist boosters"]
  CoreContext -->|Routine healthy adult| RoutineAdult["AAHA 2022: routine titering<br/>not usually advised at current intervals<br/>WSAVA: optional adult interval guide"]

  PupCheck --> CoreResult{"What the result means"}
  ReactCheck --> CoreResult
  HesCheck --> CoreResult
  RoutineAdult --> CoreResult

  CoreResult -->|Detectable antibody| ImmPres["Documents a B-cell and helper T-cell response<br/>AAHA: not automatically protection"]
  CoreResult -->|Completely negative| Susc["CAVIDS: highly likely to benefit from a dose<br/>Previously vaccinated adults: memory cells may persist"]

  RabiesFlow --> RabiesContext{"Domestic versus international?"}
  RabiesContext -->|Licensing, boarding, local law| DomRabies["Certificate and tag, not a titer<br/>NASPHV guidance; FL s. 828.30; IN 345 IAC"]
  DomRabies --> DocReq["Veterinarian rabies certificate and tag<br/>or a vet-certified exemption if the state allows one"]

  RabiesContext -->|Cross-border movement| IntTravel["The setting that requires a titer"]
  IntTravel --> CDCReq["CDC import: at least 0.5 IU/mL<br/>CDC-approved laboratory only<br/>Draw at least 30d after first valid vaccine<br/>and at least 28d before entry"]
  IntTravel --> ExportReq["Example: Japan MAFF-approved lab<br/>at least 0.5 IU/mL, valid 2 years from draw<br/>180-day wait after sampling"]

What a Dog Vaccine Titer Actually Measures

A vaccine titer measures the concentration of circulating antibodies in a dog's blood serum directed against a targeted antigen. In veterinary immunology, titers are primarily utilized to assess humoral responses to modified-live virus (MLV) vaccines. However, interpreting these measurements requires a clear understanding of laboratory methodology, because the term titer is frequently applied to two fundamentally different diagnostic formats: quantitative functional bioassays and qualitative in-clinic screening devices.

According to the CAVIDS Titer Testing Laboratory at the University of Wisconsin–Madison, a true quantitative titer is an endpoint dilution assay: how many times serum can be diluted and still neutralize or inhibit living virus. In-clinic yes/no screens are not titers in that sense, because they have no functional endpoint. AAHA 2022 reports that laboratories determining titers have generally used virus neutralization (VN) for canine distemper and hemagglutination inhibition (HI) for parvovirus—bioassays reported as antibody dilutions. TVMDL illustrates that menus are not uniform: it offers distemper by indirect fluorescent antibody (IFA), parvovirus by HI, and adenovirus type 1 by virus neutralization. Those numeric reports are still not the same as an in-clinic positive/negative screen.

In contrast, many primary-care clinics use point-of-care ELISA antibody screens. While convenient, CAVIDS and the Texas A&M Veterinary Medical Diagnostic Laboratory (TVMDL) emphasize that in-clinic ELISA kits are screening tests rather than quantitative functional titers. TVMDL's canine ELISA vaccine panel, for example, reports only positive or negative as a vaccination-status screen and is not for diagnosing infection. AAHA 2022 warns that, depending on how the test antigen is prepared, ELISA tests can measure antibody responses not involved in protection, such as responses to internal nuclear proteins.

Furthermore, commercial diagnostic test menus vary significantly across academic institutions. TVMDL, for example, offers canine distemper screening via indirect fluorescent antibody (IFA) assays alongside parvovirus HI panels, illustrating that even accredited veterinary reference centers utilize different testing methodologies. The Kansas State Veterinary Diagnostic Laboratory (KSVDL) notes that not all laboratories that determine titers are accredited and that not all test methods are equally accurate.

Once maternally derived antibodies have disappeared, AAHA 2022 states that any detectable antibody means an immune response involving at least B cells and helper T cells has occurred. The same page warns that a titer, almost regardless of the amount, is not necessarily indicative of protection or susceptibility: disease outcome depends on host, pathogen, and environmental cofactors, not on one laboratory number.

When Titers Are Useful: AAHA's Short List and the Puppy Check

Modified-live core vaccines have a long duration of immunity—AAHA's commonly used interval is three years—and WSAVA 2024 cites peer-reviewed evidence that immunity often lasts many years. For healthy dogs already on those intervals, the 2022 AAHA Guidelines explicitly state that routine titer testing to decide whether to revaccinate at currently recommended intervals is not usually advised. WSAVA is more willing to use serology to help optimize adult revaccination intervals, while also stating that veterinarians should not feel obliged to adopt titre testing. KSVDL, as a diagnostic laboratory, describes annual core (DA2P) titers after the initial series as one way to assess booster need. Those are different professional positions, not a single clinic rule.

AAHA's Three Adult Exceptions — and Other Clinical Uses

AAHA names three adult situations in which titer testing is an exception to the usual advice against routine testing. Puppy end-of-series checks and dogs with unknown histories are additional clinical uses described by WSAVA, CAVIDS, KSVDL, and Today's Veterinary Practice—not extra AAHA exceptions:

1. Documented Adverse Vaccine Reaction History: AAHA includes dogs with a history of adverse vaccine responses among the exceptions to routine titering. A core-virus titer can show whether circulating antibody is already detectable, which the veterinarian may use when deciding whether another dose is medically justified. Detectable antibody is still not, in AAHA's words, necessarily indicative of protection or susceptibility.

2. Suspected Vaccine-Associated Immune-Mediated Disease: AAHA also excepts cases with suspicion of vaccine-related autoimmune disease. Whether another core dose is given is a veterinarian's medical judgment for that patient; a titer can document a prior antibody response, not a legal waiver and not a guarantee that disease cannot occur.

3. Client Vaccine Hesitancy: AAHA excepts households in which owners express resistance or hesitancy to vaccination. A laboratory core titer can show whether antibody is already detectable. It does not create a legal substitute for a required rabies vaccine.

4. Unknown or undocumented vaccination history: Today's Veterinary Practice lists assessment of adult dogs with unknown vaccination history as a reason to run core antibody tests. A detectable result documents a prior immune response; a negative result does not, by itself, prove the dog was never vaccinated, because circulating antibody can decline while memory cells persist.

The Puppy End-of-Series Check: Overcoming Maternal Antibody Interference

The most biologically compelling application of titer testing occurs at the conclusion of the initial puppy series. Neonatal puppies absorb maternally derived antibodies (MDA) through colostrum shortly after birth. Those antibodies are vital for early survival, but circulating maternal IgG can bind and neutralize modified-live vaccine virus before the puppy's own B-cells mount an active response.

Maternal antibody declines over the first months of life, but the age at which it no longer blocks vaccination is unpredictable. WSAVA 2024 notes that some puppies still have interfering maternal antibody at 16 weeks, which is why that guideline either titers at or after 20 weeks or recommends an additional core dose at about 26 weeks. If a puppy's last dose is given while maternal antibody still blocks the vaccine virus, that dose may not immunize, and the puppy can be unprotected once the passive antibody finally disappears.

To confirm that a puppy has successfully seroconverted, the WSAVA 2024 Guidelines recommend collecting a serum sample at or after 20 weeks of age, at least four weeks following the final dose of the core series. A positive titer at 20 weeks proves that endogenous active immunization occurred, because maternal IgG has completely cleared by this time. CAVIDS provides practical timing rules based on methodology: if testing with a quantitative laboratory bioassay (VN or HI), blood can be drawn at 18 weeks (provided vaccinations continued to 16 weeks); if using an in-clinic ELISA kit, CAVIDS recommends delaying the test until 24 weeks, because semi-quantitative point-of-care screens cannot differentiate residual low-level passive maternal antibody from nascent active immunity as reliably.

Interpreting Negative Results in Previously Vaccinated Adults

A frequent point of clinical confusion is the interpretation of a negative or undetectable antibody titer in an adult dog that completed a full puppy series and received subsequent boosters. A negative titer does not automatically establish clinical susceptibility. As detailed in Today's Veterinary Practice, circulating serum IgG concentrations naturally decline over time in the absence of repeated viral antigen exposure. However, immune memory resides in long-lived memory B-lymphocytes and primed helper and cytotoxic T-lymphocytes sequestered within lymphoid tissues.

Today's Veterinary Practice explains that exposure to virulent virus is expected to rapidly boost antibody and protect—a process termed the anamnestic response. Laboratory assays cannot measure that memory-cell reserve. CAVIDS still concludes that an animal with a completely undetectable titer is highly likely to benefit from a vaccine dose, and a puppy that is antibody-negative after the initial series is considered susceptible if exposed.

Where Titers Stop: Rabies Law and Non-Core Vaccines

While core viral titers provide invaluable clinical insight, veterinary medicine recognizes strict boundaries beyond which titers cease to be informative or legally valid. These boundaries divide into two domains: the legal exceptionalism of rabies virus, and the biological limitations of non-core bacterins.

The Legal Exceptionalism of Rabies Virus

Rabies is a neurotropic rhabdovirus causing acute, fatal encephalitis with a near-100% case fatality rate across all mammalian species, including humans. Because of its grave zoonotic risk, rabies control is not left to private medical discretion between a pet owner and a veterinarian; it is strictly regulated by state statutory codes, county health departments, and municipal animal control authorities.

The same boundary appears in the NASPHV Compendium of Animal Rabies Prevention and Control and in the AAHA 2022 rabies chapter: antibody titer levels as correlates of protection have not been established for rabies, and serologic testing is not considered a substitute for vaccination. NASPHV explains that other immunologic factors also play a role in preventing rabies and cannot yet be well measured or interpreted. NASPHV states that evidence of circulating rabies virus antibodies should not be used as a substitute for current vaccination in managing rabies exposures or determining the necessity of booster vaccinations.

A titer report does not change those public-health rules. If a dog bites a person, local authorities typically require a short observation period or, if the animal cannot be observed, euthanasia and laboratory testing of brain tissue—not a four-month quarantine based on a lab titer. If an unvaccinated dog is exposed to a rabid or suspected-rabid animal, the 2016 NASPHV Compendium recommends euthanasia or, if the owner declines, strict quarantine for four months in dogs and cats (six months in ferrets). State and local law can be stricter or more specific; a high rabies antibody number on a lab report is not a substitute for current vaccination in either setting.

Why Non-Core Vaccines Cannot Be Titered for Immunity

Dog owners frequently inquire whether titer testing can be performed for non-core vaccinations, such as leptospirosis, Lyme disease (Borrelia burgdorferi), kennel cough (Bordetella bronchiseptica), and canine infectious respiratory disease agents. Both CAVIDS and KSVDL unequivocally emphasize that titer testing is clinically meaningless for determining protective immunity against non-core antigens.

The reasons for this biological limitation are twofold:

• Absence of Defined Protective Thresholds: CAVIDS states that protective thresholds have been determined for the core viruses it tests, while AAHA 2022 publishes no protective titer values and emphasizes that the supporting data are limited. For non-core antigens, CAVIDS and KSVDL agree that no protective antibody threshold is known for Leptospira, Bordetella, or Lyme disease. Laboratories cannot state whether a specific numeric value confers resistance.

• Bacterin Immunology and Non-Sterilizing Immunity: Non-core vaccines predominantly consist of killed bacterial bacterins or surface protein subunits. Bacterins stimulate short-lived humoral responses, with serum antibody concentrations dropping significantly within 6 to 12 months. Furthermore, bacterin immunity is often non-sterilizing: it decreases bacterial shedding and reduces clinical illness severity, but does not completely prevent mucosal colonization or systemic infection.

Diagnostic confusion frequently arises because diagnostic laboratories offer antibody tests for these pathogens. For example, TVMDL offers Leptospira Microscopic Agglutination Testing (MAT) panels that report numerical titers against various serovars. TVMDL describes MAT panels as detecting antibodies due to vaccination or natural exposure and reporting a numeric titer—a diagnostic exposure or vaccination-status question, not a stated protective-immunity threshold for deciding boosters.

Two Verified States: Certificates, Tags, and Exemptions

Because rabies legislation in the United States is enacted at the state and municipal levels rather than through a uniform federal mandate, statutory frameworks diverge across borders. To illustrate how state laws operationalize rabies compliance, examine two contrasting jurisdictions: Indiana and Florida. These states serve as regulatory case studies, not a nationwide survey; pet owners must consult their local jurisdiction for applicable statutes.

Indiana: Certificates, Tags, and No Exemptions

In Indiana, rabies control is governed under administrative rule 345 IAC 1-5-2 and penal code IC 35-46-3-1. Indiana enforces a strict regulatory framework:

• Mandatory Vaccination Age & Accreditation: All dogs, cats, and ferrets three months of age and older must be vaccinated against rabies by a veterinarian licensed to practice in Indiana and accredited by the USDA under 9 CFR Subchapter J, using a USDA-licensed animal vaccine administered in accordance with product labeling.

• Triplicate Certification & Numbered Metallic Tag: Upon administration, the veterinarian must complete a vaccination certificate or computerized record in triplicate and distribute copies as the rule requires (owner, veterinarian, and county health officer on request). The veterinarian also issues a rabies identification tag that includes the veterinarian's or clinic's name and telephone number and a unique identification number.

• Explicit Titer Prohibition: The Indiana State Department of Health states that a rabies antibody titer cannot be used in lieu of rabies vaccination for any dog, cat, or ferret.

• Exemption Ban: Indiana state regulations do not permit medical exemptions from rabies vaccination. Even if a patient suffers from severe chronic illness, the law provides no statutory waiver.

• Penalties: Under IC 35-46-3-1, knowingly harboring an unvaccinated dog over six months of age is a Class C infraction. If an unvaccinated dog bites a person and causes bodily injury, the offense is elevated to a Class B misdemeanor.

Florida: Statutory Titer Ban and Veterinarian-Certified Exemptions

Florida approaches rabies regulation under Florida Statutes s. 828.30, providing a clear statutory contrast to Indiana:

• Mandatory Vaccination Schedule: Dogs, cats, and ferrets four months of age and older must be vaccinated by a licensed veterinarian with a USDA-licensed vaccine. Owners must have the animal revaccinated 12 months after the initial vaccination; thereafter the interval follows the vaccine manufacturer's directions.

• Statutory Neutralizing Antibody Ban: Florida Statute s. 828.30(1)(c) incorporates the exact NASPHV scientific standard directly into statutory law: 'Evidence of circulating rabies virus neutralizing antibodies may not be used as a substitute for current vaccination in managing rabies exposure or determining the need for booster vaccinations.'

• Veterinarian-Certified Medical Exemption: Unlike Indiana, Florida allows a medical exemption under s. 828.30(2). An animal is exempt if a licensed veterinarian has examined the animal and certified in writing that vaccination would endanger the animal's health because of age, infirmity, disability, illness, or other specific clinical considerations. The statute mandates that the animal must be vaccinated as soon as its health permits.

• Regulatory Reporting: Upon administering a vaccine, the veterinarian must provide the owner and the animal control authority with a rabies vaccination certificate using the NASPHV Rabies Vaccination Certificate or an equivalent local form that contains all NASPHV-required information.

The crucial distinction for pet owners is that in jurisdictions permitting exemptions (such as Florida), the exemption is an official written veterinary certification attesting that vaccination poses an active danger to the animal's life. It is never a laboratory antibody titer report.

The Records Comparison: What Each Document Proves

In veterinary clinical practice and pet ownership, documentation errors occur when distinct diagnostic and legal instruments are conflated. A commercial kennel, municipal licensing bureau, veterinary emergency clinic, and international border patrol agent each require different legal proof. The following comparison matrix details the five standard canine immunization and serology documents, outlining their issuing authority, biological proof, and legal acceptance.

When the Law Demands a Titer: Importing and Exporting Dogs

There is one setting in which the law itself demands a rabies titer: cross-border movement. CDC and destinations such as Japan set the laboratory, the 0.5 IU/mL pass mark, and the timing windows. Meeting that import or export rule is not the same as replacing a domestic vaccination certificate.

CDC Dog Importation Rules: The 0.5 IU/mL Benchmark

Under the CDC Dog Importation Regulations, stringent entry requirements apply to all dogs arriving in the United States from countries classified as high-risk for dog rabies virus variant (DMRVV). For foreign-vaccinated dogs originating in high-risk jurisdictions, presenting an adequate rabies serologic titer is mandatory to avoid quarantine:

• Approved Laboratory Network: The serologic titer must be performed exclusively by a CDC-approved reference laboratory. Results from non-approved commercial laboratories are categorically rejected.

• Passing Benchmark (≥0.5 IU/mL): CDC defines a passing or adequate antibody titer as at least 0.5 International Units per milliliter (IU/mL). Results are accepted only from laboratories on CDC's approved list, not from other commercial laboratories.

• Strict Timing Windows: The blood sample must be drawn at least 30 days after the dog's initial valid rabies vaccination, and at least 28 days prior to arrival at a U.S. port of entry.

• Quarantine Consequence: Foreign-vaccinated dogs arriving without an approved passing titer must undergo a mandatory 28-day quarantine at a CDC-registered animal care facility at the importer's expense.

• Lifetime Validity: A passing CDC titer remains valid for the entire lifespan of the dog, provided the animal's rabies booster vaccinations never lapse according to manufacturer labeling. If a lapse occurs, a new titer must be drawn at least 30 days after revaccination.

• U.S.-Vaccinated Dogs: For dogs vaccinated in the United States traveling abroad and returning, owners must carry the official 'Certification of U.S.-issued Rabies Vaccination' form completed by a USDA-accredited veterinarian prior to departure. USDA export health certificates issued after July 31, 2025 are no longer accepted for U.S. re-entry.

International Destination Export: The Japan Protocol

For dogs exported from the United States to rabies-free countries, foreign governments establish their own rigorous entry criteria. A prime example is Japan, whose protocol is managed through the Ministry of Agriculture, Forestry and Fisheries (MAFF) and detailed by USDA APHIS Pet Travel:

• Microchip Chronology: Dogs and cats must be identified with an ISO 11784/11785 microchip. APHIS states the pet must be microchipped on the day of or before the first rabies vaccination (with a narrow documented exception tied to the second vaccination). Doses given before that identification sequence are not counted in the usual MAFF protocol.

• Two-Dose Primary Series: The dog must receive at least two lifetime rabies vaccinations, administered at least 30 days apart.

• Designated Laboratory Titer: The titer must be performed at a laboratory approved by Japan's Minister of Agriculture, Forestry and Fisheries. APHIS lists Kansas State University Rabies Laboratory and the DoD Veterinary Food Analysis and Diagnostic Laboratory among those approved laboratories. The result must be at least 0.5 IU/mL.

• The 180-Day Waiting Period: Japan mandates that at least 180 days must elapse between the date of the blood collection for the titer test and the dog's arrival in Japan. If a dog arrives before the 180-day window expires, the remaining days must be served in physical quarantine at an Animal Quarantine Service (AQS) port facility.

• Two-Year Titer Validity: A passing titer for Japan remains valid for two years from the sampling date.

The 0.5 IU/mL Threshold: Movement Standard vs Protective Standard

Pet owners frequently ask whether an international travel titer score of 0.5 IU/mL proves their dog is immune for domestic purposes. CDC and destination rules such as Japan's use 0.5 IU/mL as a movement pass mark. That is not the same as a domestic protection standard: KSVDL states there is no agreed titer value considered protective for rabies, and a passing travel result documents meeting another jurisdiction's import rule at that time rather than replacing state vaccination law.

Furthermore, pet owners must recognize that passing an international travel titer is not guaranteed. The WSAVA 2024 Guidelines highlight published studies from the United Kingdom (Kennedy 2007; Mansfield 2004) evaluating dogs and cats vaccinated against rabies for pet travel under the European Pet Travel Scheme (PETS). These studies revealed that a substantial percentage of older animals vaccinated for the first time failed to achieve the legally required 0.5 IU/mL antibody threshold on their initial test. Younger animals demonstrated significantly higher seroconversion rates. Because Japan requires a 180-day wait after sampling, and because a first titer can fail, travel plans need months of lead time and a fallback if the first result is below 0.5 IU/mL.

Clinical Consultation Checklist: How to Use Titers With Your Vet

When approaching your veterinarian to discuss vaccine titers, following a structured clinical checklist ensures clear communication and prevents administrative disappointment:

1. Clarify Your True Objective: Determine whether you are asking a medical question ('Does my dog maintain detectable circulating antibodies against distemper and parvo?') or an administrative question ('Will this paper allow my dog into daycare, boarding, or satisfy city pet registration?').

2. Verify Third-Party Facility Acceptance in Advance: Before requesting a titer as a boarding substitute, ask the facility in writing what document it accepts. Some private kennels or daycares will take a laboratory core-virus titer in place of an annual distemper/parvo booster; that is a facility policy, not a legal rule. No private facility can waive a rabies vaccination requirement set by state or local law.

3. Select the Correct Laboratory Modality: Discuss with your veterinarian whether an in-clinic ELISA screening test or an accredited reference laboratory send-out panel (VN/HI via CAVIDS, TVMDL, or KSVDL) is appropriate. For puppies nearing 20 weeks or complex medical cases, reference laboratory quantitative dilution assays provide superior diagnostic precision.

4. Establish a Clear Plan for Undetectable Titer Results: Agree on next steps before the blood draw. If a core titer returns negative or below the laboratory's reference cutoff, the standard evidence-based clinical recommendation is to administer a single core modified-live booster.

5. Plan International Pet Travel 6 to 9 Months Early: If traveling internationally, verify microchip sequencing, CDC import requirements, and destination rules with a USDA-accredited veterinarian early enough for the 30-day post-vaccination draw window, possible retesting, and waits such as Japan's 180 days after sampling.

Sources

The clinical, immunological, and statutory standards detailed in this article are derived from peer-reviewed veterinary guidelines, diagnostic reference laboratory manuals, and official state and federal statutes:

• 2022 AAHA Canine Vaccination Guidelines — Utilization and interpretation of serologic titers — American Animal Hospital Association (AAHA). Core viral bioassay methodologies (VN, HI), ELISA limits, laboratory variability, and clinical indications for titer testing.

• 2022 AAHA Canine Vaccination Guidelines — Key Vaccination: Rabies — American Animal Hospital Association (AAHA). Public health mandates, absence of rabies protective correlates, and medical exemption guidelines.

• CAVIDS Titer Testing — Frequently Asked Questions — CAVIDS Laboratory, University of Wisconsin–Madison School of Veterinary Medicine. Endpoint dilution bioassays, non-core vaccine limitations, puppy testing intervals, and negative titer interpretation.

• Compendium of Animal Rabies Prevention and Control, 2016 — National Association of State Public Health Veterinarians (NASPHV); Journal of the American Veterinary Medical Association (JAVMA). Standard establishing that circulating rabies antibody titers cannot substitute for current vaccination.

• Rabies Information: Pet Vaccination Laws (Indiana) — Indiana State Department of Health. 345 IAC 1-5-2 and IC 35-46-3-1 on mandatory vaccination, certificates, and tags; the same page states that titers cannot replace vaccination and that exemptions are not allowed.

• Florida Statutes s. 828.30 — Rabies vaccination of dogs, cats, and ferrets (2025) — Florida Legislature. Statutory codification of the rabies neutralizing antibody substitution ban and veterinarian-certified medical exemption framework.

• Documents for Veterinarians to Complete for Dogs Being Imported into the United States — U.S. Centers for Disease Control and Prevention (CDC). Federal import regulations, 0.5 IU/mL titer requirement for high-risk countries, approved laboratories, and timing windows.

• Pet Travel From the United States to Japan — USDA Animal and Plant Health Inspection Service (APHIS). Japan MAFF protocol, microchip sequencing, designated-laboratory rabies titers, and 180-day waiting periods.

• Dog and Cat Vaccines and Titer Testing — Kansas State Veterinary Diagnostic Laboratory (KSVDL), Kansas State University. Laboratory accreditation, lack of agreed protective rabies titer values, and non-core bacterin limitations.

• WSAVA Guidelines for the Vaccination of Dogs and Cats 2024 — World Small Animal Veterinary Association (WSAVA). 20-week puppy serology testing, permanent medical record administration standards, and pet travel rabies titer failure rates in older animals.

• Antibody Titers Versus Vaccination — Today's Veterinary Practice. Memory B-lymphocyte persistence, anamnestic response mechanics, and clinical interpretation of seronegative adult dogs.

• Vaccine Titer Testing — Texas A&M Veterinary Medical Diagnostic Laboratory (TVMDL). Test catalog protocols, canine ELISA vaccination screens, distemper IFA and parvovirus HI assays, and Leptospira MAT diagnostic distinctions.